Financhill
Buy
99

HIMS Quote, Financials, Valuation and Earnings

Last price:
$61.21
Seasonality move :
12.65%
Day range:
$60.82 - $65.89
52-week range:
$13.12 - $72.98
Dividend yield:
0%
P/E ratio:
92.75x
P/S ratio:
8.65x
P/B ratio:
26.08x
Volume:
77.4M
Avg. volume:
43.5M
1-year change:
396.51%
Market cap:
$14.3B
Revenue:
$1.5B
EPS (TTM):
$0.69

HIMS Analysts' Consensus Rating

The 12 analysts providing 12-month price projections for Hims & Hers Health shares anticipate an average target of $45.25, ranging from a low estimate of $25.00 to a high estimate of $85.00. This average target implies a growth of -29.31% compared to the current stock price of $64.00.

Consensus Price Target

$45.25

Highest Price Target

$85.00

Lowest Price Target

$25.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 3 3

Hold 7 8 8

Sell 0 1 1
Consensus Hold Hold Hold

HIMS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.72% over the past day.

Buy
93
COIN alert for May 15

Coinbase Global [COIN] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock